BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7829274)

  • 1. Production of soluble HLA-class-I molecules by IFN-gamma-induced colon-adenocarcinoma cells.
    Le J; Hua JC
    Int J Cancer; 1995 Feb; 60(4):576-81. PubMed ID: 7829274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of HLA class I transcripts induced by IFN-gamma and TNF in fibroblasts: release of soluble HLA class I heavy chain and an associate protein.
    He X; Le J
    Cell Immunol; 1995 Apr; 162(1):159-68. PubMed ID: 7704905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
    Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
    Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells.
    Ponzoni M; Guarnaccia F; Corrias MV; Cornaglia-Ferraris P
    Int J Cancer; 1993 Nov; 55(5):817-23. PubMed ID: 8244579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes.
    Nilsen EM; Johansen FE; Kvale D; Krajci P; Brandtzaeg P
    Eur J Immunol; 1999 Jan; 29(1):168-79. PubMed ID: 9933098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons.
    Johnson DR; Pober JS
    Mol Cell Biol; 1994 Feb; 14(2):1322-32. PubMed ID: 8289810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-2 microglobulin in temperature-sensitive and interferon-gamma-induced exocytosis of HLA class I molecules.
    Tatake RJ; Ferrone S; Zeff RA
    Transplantation; 1992 Sep; 54(3):395-403. PubMed ID: 1412716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ethanol on the expression of HLA class I genes in human colon adenocarcinoma cell lines.
    Papavassiliou ED; Arvind P; Tsioulias GJ; Qiao L; Goldin E; Staiano-Coico L; Rigas B
    Cancer Lett; 1994 Jun; 81(1):33-8. PubMed ID: 8019985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).
    Aulitzky WE; Grosse-Wilde H; Westhoff U; Tilg H; Aulitzky W; Gastl G; Herold M; Huber C
    Clin Exp Immunol; 1991 Nov; 86(2):236-9. PubMed ID: 1934591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells.
    Suzuki S; Mita S; Kamohara H; Sakamoto K; Ishiko T; Ogawa M
    Int J Oncol; 2001 Mar; 18(3):581-6. PubMed ID: 11179490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of beta 2m-free HLA class I heavy chains in neuroblastoma cell lines.
    Marozzi A; Meneveri R; Bunone G; De Santis C; Lopalco L; Beretta A; Agresti A; Siccardi AG; Della Valle G; Ginelli E
    Scand J Immunol; 1993 Jun; 37(6):661-7. PubMed ID: 8316764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A third polypeptide associated with heavy and light chain subunits of class I HLA antigens in immune interferon-treated human melanoma cells.
    Giacomini P; Aguzzi A; Tecce R; Fisher PB; Ferrone S
    Eur J Immunol; 1985 Sep; 15(9):946-51. PubMed ID: 3930263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus.
    Bornstein J; Lahat N; Kinarty A; Revel M; Abramovici H; Shapiro S
    Cancer; 1997 Mar; 79(5):924-34. PubMed ID: 9041155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.